Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
POET Technologies Inc., a Nasdaq-listed company specializing in integrated optical engines and light sources for AI networks, announced the appointment of Sandeep Kumar as Chief Operating Officer. Dr. Kumar brings extensive semiconductor operations experience from Silicon Labs and other industry leaders. His immediate focus will be on preparing POE…
Hub Group, Inc. has filed a Notification of Late Filing for its quarterly report and disclosed delays in its annual report due to identified accounting inaccuracies requiring restatement of financials for 2023, 2024, and part of 2025. Despite operational growth in intermodal and logistics, brokerage volume declined as the company focuses on profita…
Australia's Treasury has modelled a severe scenario in its budget papers in which an escalation of the conflict in Iran disrupts regional energy and export infrastructure, lifting oil to $200 per barrel in the July-September window and triggering a quarterly contraction, a sharp rise in inflation and higher unemployment.
Qualcomm remains uniquely positioned where mobile connectivity, edge AI, and automotive telematics converge. This trade idea lays out a mid-term long with a clear entry, target and stop, aiming to capture incremental revenue growth from chipset ramps and licensing leverage while respecting execution and policy risks.
Barclays Research rates European Value shares Positive after they led factor performance on earnings days in Q1 2026, supported by a pickup in blended EPS growth and improving earnings momentum. Momentum positioning looks stretched, while Value's sector tilt toward Financials and Cyclicals and a lower forward P/E versus history underpin the bank's …
Government data released on Tuesday showed India’s year-on-year consumer price inflation rose to 3.48% in April, lifted by firmer food prices. Economists warn that elevated crude prices linked to the Middle East conflict, a weaker rupee, fertiliser cost pressures and the prospect of a below-normal monsoon raise the risk of higher inflation ahead, t…
Under Armour said it expects fiscal 2027 revenue to decline slightly and projected adjusted earnings per share well below analyst forecasts, as soft consumer spending and broader economic uncertainty damp demand in its core North American market. The announcement sent the stock down 12% in premarket trading and renewed questions about the company’s…
Bank of America card transaction data indicate total household spending increased 4.8% year-over-year in April and rose 0.6% month-over-month on a seasonally adjusted basis. Growth across spending categories was mixed: higher gas spending driven by prices contrasted with continued strength in online retail, while department stores, home improvement…
OpenAI is granting select European companies access to its newest models, including GPT-5.5-Cyber, through a program aimed at equipping trusted defenders with tools for identifying and responding to vulnerabilities. The initiative covers firms across finance, telecommunications, energy and public services, and coincides with broader company moves t…
Crown Holdings (CCK) trades near $100 after a modest pullback. With nearly $1.0B in free cash flow, a 35% dividend hike, and an EV/EBITDA of ~8x, the risk-reward favours a long. This trade targets a re-rating to $120 over the next 180 trading days, with a protective stop at $92.
IREN is a vertically integrated, renewable-powered data center platform that just closed multi-billion dollar AI contracts and targeted acquisitions. The stock sold off after a $2bn convertible note offering, creating a long entry at $55.63. If execution on capacity build, enterprise deals and software stack integration go to plan, ARR could scale …
Unicycive Therapeutics announced its first quarter 2026 financial results alongside an optimistic update on the FDA review process for oxylanthanum carbonate (OLC), a novel phosphate binder targeting hyperphosphatemia in chronic kidney disease dialysis patients. The company highlighted its preparedness for a potential product launch following a Jun…
NeurAxis, Inc. reported a record first quarter for 2026 with revenues up 80% year-over-year to $1.6 million driven by the implementation of the Category I CPT code for their IB-Stim device. The company expanded gross margin and reduced operating losses while securing significant regulatory and commercial milestones including Veterans Affairs contra…
Achieve Life Sciences announced key senior appointments to its board and commercial team, including executives from Verona Pharma, signaling a strong push towards commercializing cytisinicline, a novel treatment for nicotine dependence with FDA review anticipated in June 2026. These leadership additions come shortly after a substantial $354 million…
Arvinas, Inc. announced FDA approval of VEPPANU™ (vepdegestrant), the first PROTAC therapy approved for treating ESR1-mutated, ER+/HER2- advanced breast cancer, marking a milestone for the company and the PROTAC modality. The company reported strong clinical progress in its pipeline including positive Phase 1 data for ARV-102 in Parkinson’s disease…
Semiconductor shares slid after a senior South Korean official suggested distributing a 'citizen dividend' funded by taxes on AI profits. The initial reaction sent the Kospi tumbling as much as 5.1%, wiping out over $300 billion in market value before officials moved to clarify the remarks. Major chipmakers including Samsung Electronics, SK Hynix, …
CorVel Corporation will host a live webcast on May 20, 2026, to discuss its quarterly and fiscal earnings, featuring its CEO and CFO. The webcast will include insights into financial performance, strategic initiatives, and a Q&A session. The company highlights its focus on technology-driven risk management solutions in healthcare-related sectors.
Prelude Therapeutics reported Q1 2026 financial results highlighting progress in its oncology pipeline including initiation of a Phase 1 study for PRT12396, a mutant-selective JAK2V617F inhibitor, advancement of PRT13722, a selective oral KAT6A degrader for ER+ breast cancer, and development of novel degrader antibody conjugates. The company extend…
Beamr Imaging Ltd. announced it will demonstrate its machine-learning safe video data compression technology for autonomous vehicles at the Smart Mobility Summit 2026. The technology reduces video file sizes significantly, while improving machine learning model accuracy for depth estimation and object detection, thereby lowering storage and network…
Climb Bio, Inc., a clinical-stage biotech company specializing in immune-mediated disease therapeutics, announced executive participation in upcoming investor conferences including H.C. Wainwright BioConnect and Jefferies Global Healthcare. The company plans to present updates on its clinical programs targeting B-cell mediated diseases and IgA neph…
JSC Kaspi.kz announced an Extraordinary General Meeting of Shareholders to be held on June 11, 2026, to approve the payment of dividends on common shares, recommend the amount per share, and address standard governance issues. The Board recommends an 850 KZT dividend per common share with a record date of June 10, 2026.
LiveOne's subsidiary PodcastOne has received $5.5 million from exercising warrants at $3 per share. This capital infusion strengthens LiveOne's balance sheet and supports expansion in podcast, TV networks, celebrity brands, and AI initiatives leveraging a large content library. The company is evaluating strategic alternatives including podcast netw…
SOLV Energy, Inc. (Nasdaq: MWH) announced its Q1 2026 financial results showing a 66% increase in revenue to $677 million and a 102% growth in gross profit to $119 million year-over-year. Despite a net loss primarily due to a one-time non-cash expense tied to legacy equity award modifications, the company achieved a 174% increase in adjusted EBITDA…
Legend Biotech Corporation announced robust first-quarter 2026 results, highlighted by a 62% increase in CARVYKTI® net trade sales compared to Q1 2025, driven by expanded availability across 18 global markets. The company improved manufacturing efficiency, achieved significant milestones under the Janssen collaboration, and reported a substantial r…
Arvinas, Inc. and Pfizer entered into an agreement with Rigel Pharmaceuticals granting Rigel exclusive global rights to develop, manufacture, and commercialize VEPPANU (vepdegestrant), the first FDA-approved PROTAC drug for certain advanced breast cancers. Arvinas and Pfizer will receive $85 million upfront combined with potential milestones totali…
